Pathogenic Study of Adult Immune Enteropathies

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Study ID
NCT04280510
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Blood sample collection; gastrointestinal biopsy — GENETIC
    Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...

Study Details

The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.

Key Dates

First listed
Feb 21, 2020
Start date
Feb 27, 2020
Status verified
Sep 2025
Primary completion
Feb 27, 2030
Completion
Feb 27, 2033

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Active coeliac patients
    Patients with active coeliac disease
  • Arm: Treated coeliac patients
    Patients with coeliac disease on gluten free diet
  • Arm: Sprue type I
    Patients with refractory coeliac disease of type I
  • Arm: Sprue type II
    Patients with refractory coeliac disease of type II
  • Arm: Intestinal Lymphoproliferations
    Patients with intestinal lymphoproliferations
  • Arm: Non coeliac enteropathies
    Patients with non coeliac immune-mediated enteropathy
  • Arm: Patients without neoplastic or inflammatory intestinal disease
    Patients without neoplastic or inflammatory intestinal disease

Primary Outcome Measure

Intestinal Lymphocytes count [ Time Frame: Baseline ]

Central Contacts

Find similar trials

Related Studies